Suppr超能文献

非小细胞肺癌患者治疗前体能测试与治疗并发症的相关性:系统综述。

Associations between pretreatment physical performance tests and treatment complications in patients with non-small cell lung cancer: A systematic review.

机构信息

Department of Clinical Epidemiology, VieCuri Medical Center, Venlo, the Netherlands; Adelante Rehabilitation Center, Venlo, the Netherlands; Department of Epidemiology, GROW School for Oncology and Developmental Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.

Department of Clinical Epidemiology, VieCuri Medical Center, Venlo, the Netherlands; Department of Epidemiology, GROW School for Oncology and Developmental Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; Department of Clinical Physical Therapy, VieCuri Medical Center, Venlo, the Netherlands.

出版信息

Crit Rev Oncol Hematol. 2021 Feb;158:103207. doi: 10.1016/j.critrevonc.2020.103207. Epub 2020 Dec 28.

Abstract

This systematic review evaluated which outcome variables and cut-off values of pretreatment exercise tests are associated with treatment complications in patients with stage I-III non-small cell lung cancer (NSCLC). PRISMA and Cochrane guidelines were followed. A total of 38 studies with adult patients undergoing treatment for stage I-III NSCLC who completed pretreatment exercise tests, and of whom treatment-related complications were recorded were included. A lower oxygen uptake at peak exercise amongst several other variables on the cardiopulmonary exercise test and a lower performance on field tests, such as the incremental shuttle walk test, stair-climb test, and 6-minute walk test, were associated with a higher risk for postoperative complications and/or postoperative mortality. Cut-off values were reported in a limited number of studies and were inconsistent. Due to the variety in outcomes, further research is needed to evaluate which outcomes and cut-off values of physical exercise tests are most clinically relevant.

摘要

本系统评价评估了哪些预处理运动试验的结局变量和截断值与 I-III 期非小细胞肺癌(NSCLC)患者的治疗并发症相关。本研究遵循 PRISMA 和 Cochrane 指南。共纳入 38 项研究,这些研究纳入了接受 I-III 期 NSCLC 治疗且完成预处理运动试验的成年患者,记录了与治疗相关的并发症。在心肺运动试验中,有几个其他变量(如峰值摄氧量)和在现场测试(如递增式穿梭步行试验、爬楼梯试验和 6 分钟步行试验)中的表现较差与术后并发症和/或术后死亡率的风险增加相关。少数研究中报告了截断值,但并不一致。由于结局的多样性,需要进一步的研究来评估哪些体力活动试验的结局和截断值最具临床相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验